Blog
Interview with Steve Adubato
Listen to Steve Adubato interview Alzheimer's New Jersey CEO Ken Zaentz about the important of helping those coping with Alzheimer's in New Jersey.
Our Alzheimer’s Story
Jennifer and I were married for 58 years. If couples can say “we are having a baby,” I can say that “we had Alzheimer’s disease.” When she became ill with Alzheimer’s, her story became [View More]
Andrea’s Alzheimers Story
My mom was such a lively and outgoing person, turning strangers into friends anywhere she went. She was like a superwoman; involved in everything her three daughters did like dance and art classes while [View More]
Activities for Persons with Alzheimer’s Disease
In his 1996 novel, The Notebook, author Nicholas Sparks describes a scene in which the main characters, Noah and Allie, learn that Allie has Alzheimer’s disease. “Alzheimer's... It is a barren disease, as empty and [View More]
Another Promising Treatment for Alzheimer’s disease
Last week, Eli Lilly and Company announced that it has applied for U.S Food and Drug Administration (FDA) approval for its Alzheimer’s treatment, donanemab, and expects an FDA decision by the end of 2023. [View More]
FDA Grants Full Approval to Leqembi® and Medicare Expands Coverage
On Thursday, July 6, Leqembi® (lecanemab – irmb), became the first beta-amyloid targeting medication for the treatment of Alzheimer’s disease to receive full approval from the U.S. Food and Drug Administration (FDA). The drug, from pharmaceutical [View More]